Geroscience-native de novo design

De novo longevity chemistry,measured — not promised.

Target × tissue × hallmark. Every candidate ships a route you can run and an interval on every score.

GQ·259 · mTORC1 inhibitor✓ Pass
2D chemical structure of candidate GQ-2592D structure
SMILESCOC1=C/C(=C\C(=O)C(=O)Nc2nc(O)c3cc(C)ccc3n2)OC(O)=C1
Designed de novo · not from a catalogue
Predicted effect on aging signature
0.57across 10 tissues
A directional prior — disclosed, not a lifespan promise
Hallmarks of aging engaged3 of 12
nutrient-sensing · autophagy · proteostasis · senescence
Can it be made?2-step verified route
Is it drug-like?QED 0.55 · MW 369
Is it safe so far?7 / 7 ADMET in range
Real candidate · whole-body mTORC1 run
Built on the world’s aging data
GenAgeCellAgeOpen TargetsDrugAgeChEMBLGTExLópez-Otín hallmarks
How a candidate is built

Assembled from real chemistry — so the route exists before the molecule does.

01 · You choose
TargetmTORC1
TissueWhole-body
Hallmark12 scored
02 · Engine assembles
Scaffold
+
Block
Amide coupling
A named, verified reaction
03 · You get a route
12
Fragments
real, in stock
Reactions
named + verified
Candidate
makeable
2 steps✓ makeable by construction

Most generators emit a structure and guess the synthesis afterwards. We build from the reaction, so the route is not a prediction.

Published · benchmarked · disclosed

The proof, in three numbers.

Backed by a methods preprint — including the number where we fail.

Binder recovery
0.945
ROC-AUC

Recovers known binders from decoys on a scaffold-disjoint held-out split.

On novel chemotypes0.62 · disclosed
Sample efficiency
0.938
PMO AUC-top10 · QED

Level with the strongest unconstrained generators (0.94–0.95) — and ours stay makeable.

vs SOTA cluster0.94–0.95
Calibrated honesty
90%
Interval coverage

The lifespan prior is weak but real (ρ 0.182) — always shipped with its interval.

775 measured-lifespan compounds42 NIA-ITP
See all the benchmarks →PMO · recovery · MOSES · out-of-domain — reported in full, reproducible.
Target → Tissue → Candidates

Three steps. Seconds on CPU.

01

Pick a target

Eleven, ranked by human genetic evidence.

02

Set the tissue

One tissue — or whole-body, pan-aging.

03

Get candidates

Verified route and an interval on every score.

Who it's for

Built for teams hunting real longevity chemistry.

Longevity biotechs

Makeable candidates before you spend on synthesis.

Geroscience labs

A validated target → testable molecules.

Drug-hunting teams

Clean structures, ADMET, a ranked shortlist.

Every candidate is a longevity hypothesis
Target × tissue × hallmark

Designed on three axes — target, tissue, hallmark.

We fix the biology first — not a molecule in a vacuum.

01 · Axis
11

Target

Eleven validated longevity mechanisms — CD38, mTORC1, IGF1R, Bcl-2, NAMPT and more.

02 · Axis
10

Tissue

Ten tissues — or whole-body, pan-aging.

03 · Axis
12

Hallmark

Twelve hallmarks scored (López-Otín 2023).

12-hallmark engagement · GQ-2593 / 12 ≥ 0.5
GenomicTelomereEpigeneticProteostasisAutophagyNutrientMitochondriaSenescenceStem cellIntercellularInflammationDysbiosis
Drug class · Senomorphic

What this candidate engages.

The same per-hallmark score every molecule carries inside the platform.

Deregulated nutrient sensing
0.95
Disabled autophagy
0.90
Loss of proteostasis
0.70
Cellular senescence
0.45
Altered intercellular comm.
0.45
Mitochondrial dysfunction
0.40
Stem-cell exhaustion
0.40
Tissue scope — design for one, or whole-body across all ten
CNS / BrainHeartLiverSkeletal muscleImmune (PBMC)AdiposeVascularHypothalamusGutThymus★ Whole-body
From a recent run
Live output · mTORC1 · whole-body

Real molecules. Real scores. Real structures.

Top candidates from a real whole-body mTORC1 run — exactly as produced.

GQ-259✓ Pass
2D structure of candidate GQ-259
COC1=C/C(=C\C(=O)C(=O)Nc2nc(O)c3cc(C)ccc3n2)OC(O)=C1
mTORC1 inhibitor
Whole-body · pan-aging
Phenotype · mechanistic prior
+2.4 yrs
Clock
0.57
Reversal
0.41
SASP ↓
Hallmarks 3 / 12 ≥ 0.5Senomorphic
369
MW
0.55
QED
2.0
LogP
hERG 0.21Ames 0.23ADMET ✓ · 2-step route
GQ-260✓ Pass
2D structure of candidate GQ-260
CCCC(=O)Nc1ccc(S(N)(=O)=O)cc1Oc1cccnc1
mTORC1 inhibitor
Whole-body · pan-aging
Phenotype · mechanistic prior
+2.7 yrs
Clock
0.63
Reversal
0.49
SASP ↓
Hallmarks 3 / 12 ≥ 0.5Senomorphic
335
MW
0.84
QED
2.26
LogP
hERG 0.15Ames 0.02ADMET ✓ · 2-step route
What makes it different

Built for aging biology, not retrofitted from oncology.

Built for aging

Twelve hallmarks. Not an oncology retrofit.

Honest uncertainty

Every score ships its interval and its accuracy.

CPU, seconds

No GPU. Every candidate carries a real route.

11 targets · 10 tissues

One pathway, or whole-body.

Eleven validated targets · genetics-ranked

The pathways longevity actually runs on.

Design against one mechanism, or switch to whole-body mode and optimise across all ten tissues at once.

CD38Inhibitor

NAD⁺ → SIRT1 / PGC-1α metabolic axis

SIRT6Activator

Chromatin guardian; NF-κB co-repression

NAMPTActivator

Rate-limiting enzyme of NAD⁺ salvage

Bcl-2PPI inhibitor

Senolytic clearance of senescent cells

mTORC1Inhibitor

Autophagy gate; canonical longevity axis

AMPKActivator

Cellular energy sensor; ADaM-site activation

NF-κB / IKKβInhibitor

Suppress the SASP / inflammaging

p21 (CDKN1A)Senostatic

Silence the senescence secretory phenotype

MEK1Inhibitor

RAS–MEK–ERK inflammaging axis

NRF2Activator

Master antioxidant-response regulator

IGF1RInhibitor

IGF-1 / insulin (daf-2) longevity axis

Your target not here?Tell us the mechanism — we scope new targets per program.Talk to us →
Honesty-first
We don't ship a score we can't measure. Where the signal is strong, we say so. Where it's weak, we show the interval — and let your chemists decide.

A field burned by overpromising — we measure, or we don't ship.

Bring your target. We'll bring the chemistry.

Novel, makeable candidates for your longevity program.